Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination

March 29, 2026 updated by: Xiong hao, Guangdong Provincial People's Hospital

Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination: An Empirical Analysis Based on the "Answering-Generating" Closed Loop and Transformation of Competency Assessment

This is a cross-sectional study that primarily employs quantitative analysis, supplemented by qualitative assessment. The research is conducted in two stages: Phase I consists of a model performance comparison experiment, and Phase II involves an item quality evaluation experiment. The entire study adheres to the principles of single-blinding, randomization, and standardization to ensure scientific rigor and reproducibility.

The single-blind design is implemented during the "standardized testing" phase, where the system intersperses AI-generated items with those authored by human experts. Participants remain blinded to the source of each item (AI-generated vs. human-authored) throughout the testing and scoring processes, thereby ensuring the objectivity of the evaluation results.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China
        • Recruiting
        • Guangdong Provincial People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Medical students currently enrolled in a Standardized Residency Training (SRT) program.

Description

Inclusion Criteria:

  • 1.Professional Status: Medical students currently enrolled in a Standardized Residency Training (SRT) program.

    2.Educational Background: Holders of a Bachelor of Medicine degree or higher, with foundational clinical knowledge.

    3.Informed Consent: Voluntarily participate in the study and provide written informed consent.

    4.Technical Competency: Proficient in using digital platforms to complete assessments and scoring.

Exclusion Criteria:

  • 1.Conflict of Interest: Individuals involved in the AI model training, prompt engineering, or the creation of the human-authored question bank for this study.

    2.Inability to Complete: Presence of visual/auditory impairments or severe illness that precludes completion of the assessment within the specified time.

    3.Investigator's Discretion: Any other condition that, in the opinion of the investigator, renders the participant unsuitable for the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparative Analysis of Item Accuracy
Time Frame: Baseline
The investigators will evaluate the average accuracy rates coefficients of AI-generated items compared to human-generated items
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2025

Primary Completion (Estimated)

March 30, 2026

Study Completion (Estimated)

March 30, 2026

Study Registration Dates

First Submitted

March 22, 2026

First Submitted That Met QC Criteria

March 29, 2026

First Posted (Actual)

April 1, 2026

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 29, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KY2025-1298-02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on AI (Artificial Intelligence)

Subscribe